Home › Membranous Glomerulonephritis
Membranous Glomerulonephritis clinical trials recruiting in the U.S.
7 studies for Membranous Glomerulonephritis are recruiting participants at sites across the United States.
Cities with the most studies
- Washington, DC3 studies
- Cleveland, OH3 studies
- Durham, NC3 studies
- New York City, NY3 studies
- Baltimore, MD3 studies
- Miami, FL3 studies
- Philadelphia, PA3 studies
- Ann Arbor, MI3 studies
- Spokane, WA3 studies
By state
- California3 studies
- Florida3 studies
- Maryland5 studies
- Michigan3 studies
- Missouri3 studies
- New York3 studies
- North Carolina3 studies
- Ohio3 studies
- Pennsylvania3 studies
- Washington3 studies
Recently updated studies
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
RecruitingPhase 2
Ages 18 to 115 · All sexes · Updated Oct 2, 2026 · NCT06664814A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Oct 1, 2026 · NCT07851220Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT00977977Belimumab With Rituximab for Primary Membranous Nephropathy
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855Nephrotic Syndrome Study Network
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000NEPTUNE Match Study
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
RecruitingObservational study
Ages 2 and older · All sexes · Updated Dec 22, 2025 · NCT05505500From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.